bruton tyrosine kinase inhibitor
Showing 1 - 1 of 1
REfractorinesS to Ibrutinib BTKi and Systemic Targeted Therapy
Not yet recruiting
- CLL, Relapsed
- +3 more
-
Clermont-Ferrand, France
- +7 more
Nov 16, 2022